.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Deloitte
Accenture
Moodys
Federal Trade Commission
Chinese Patent Office
Express Scripts
US Department of Justice
Citi

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075520

« Back to Dashboard
NDA 075520 describes NORTRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Pharm Assoc, Taro Pharm, Teva, Mylan, Aurolife Pharma Llc, Mayne Pharma, Idt Australia Ltd, and Taro, and is included in twelve NDAs. It is available from thirty-three suppliers. Additional details are available on the NORTRIPTYLINE HYDROCHLORIDE profile page.

The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There are ten drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

Summary for NDA: 075520

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 075520

Suppliers and Packaging for NDA: 075520

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORTRIPTYLINE HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL 075520 ANDA Medsource Pharmaceuticals 45865-729 45865-729-30 30 CAPSULE in 1 BOTTLE (45865-729-30)
NORTRIPTYLINE HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL 075520 ANDA AvPAK 50268-603 50268-603-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-603-15) > 1 CAPSULE in 1 BLISTER PACK (50268-603-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 50MG BASE
Approval Date:May 8, 2000TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 75MG BASE
Approval Date:May 8, 2000TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 25MG BASE
Approval Date:May 8, 2000TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
McKesson
Healthtrust
Teva
Chinese Patent Office
AstraZeneca
Moodys
Chubb
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot